{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:30:04Z","timestamp":1761921004836,"version":"build-2065373602"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.msard.2022.103664","type":"journal-article","created":{"date-parts":[[2022,2,12]],"date-time":"2022-02-12T18:54:48Z","timestamp":1644692088000},"page":"103664","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Centrally-located transverse myelitis would facilitate the differentiation of NMOSD and MOG-AD from MS"],"prefix":"10.1016","volume":"60","author":[{"given":"Masoud","family":"Etemadifar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehri","family":"Salari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Reza","family":"Etemadifar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatemeh","family":"Sabeti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sepand Tehrani","family":"Fateh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2018-3436","authenticated-orcid":false,"given":"Zahra","family":"Aminzade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.msard.2022.103664_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2377-13-33","article-title":"Modifications of longitudinally extensive transverse myelitis and brainstem lesions in the course of neuromyelitis optica (NMO): a population-based, descriptive study","volume":"13","author":"Asgari","year":"2013","journal-title":"BMC Neurol."},{"key":"10.1016\/j.msard.2022.103664_bib0032","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.msard.2018.08.008","article-title":"Brain and spinal cord lesion criteria distinguishes AQP4-positive neuromyelitis optica and MOG-positive disease from multiple sclerosis","volume":"25","author":"Bensi","year":"2018","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"6","key":"10.1016\/j.msard.2022.103664_bib0026","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1177\/1352458520939008","article-title":"Evaluation of brain and spinal cord lesion distribution criteria at disease onset in distinguishing NMOSD from MS and MOG antibody-associated disorder","volume":"27","author":"Cai","year":"2021","journal-title":"Mult. Scler. J."},{"issue":"8","key":"10.1016\/j.msard.2022.103664_bib0022","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1177\/1352458519849517","article-title":"Brain and spinal MRI features distinguishing MS from different AQP4 antibody serostatus NMOSD at disease onset in a cohort of Latin American patients","volume":"26","author":"Carnero Contentti","year":"2020","journal-title":"Mult. Scler. J."},{"issue":"2","key":"10.1016\/j.msard.2022.103664_bib0023","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S1474-4422(18)30460-5","article-title":"Spinal cord involvement in multiple sclerosis and neuromyelitis optica spectrum disorders","volume":"18","author":"Ciccarelli","year":"2019","journal-title":"Lancet Neurol."},{"issue":"8","key":"10.1016\/j.msard.2022.103664_bib0017","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1177\/1352458519849511","article-title":"Frequency and characteristics of short versus longitudinally extensive myelitis in adults with MOG antibodies: a retrospective multicentric study","volume":"26","author":"Ciron","year":"2020","journal-title":"Mult. Scler. J."},{"issue":"10","key":"10.1016\/j.msard.2022.103664_bib0021","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/s41393-018-0143-6","article-title":"Short-segment transverse myelitis lesions in a cohort of Latin American patients with neuromyelitis optica spectrum disorders","volume":"56","author":"Contentti","year":"2018","journal-title":"Spinal Cord"},{"issue":"3","key":"10.1016\/j.msard.2022.103664_bib0024","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1001\/jamaneurol.2016.5441","article-title":"Association of extension of cervical cord lesion and area postrema syndrome with neuromyelitis optica spectrum disorder","volume":"74","author":"Dubey","year":"2017","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.msard.2022.103664_bib0028","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jns.2016.11.035","article-title":"The characteristics of spinal imaging in different types of demyelinating diseases","volume":"372","author":"Dumrikarnlert","year":"2017","journal-title":"J. Neurol. Sci."},{"issue":"23","key":"10.1016\/j.msard.2022.103664_bib0006","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1212\/WNL.0000000000003395","article-title":"Gray matter MRI differentiates neuromyelitis optica from multiple sclerosis using random forest","volume":"87","author":"Eshaghi","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2022.103664_bib0016","doi-asserted-by":"crossref","DOI":"10.1177\/1756286419898594","article-title":"Short segment myelitis as the initial and only manifestation of aquaporin-4 immunoglobulin G-positive neuromyelitis optica spectrum disorders","volume":"13","author":"Fang*","year":"2020","journal-title":"Ther. Adv. Neurol. Disord."},{"issue":"1","key":"10.1016\/j.msard.2022.103664_bib0013","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1001\/jamaneurol.2014.2137","article-title":"Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders","volume":"72","author":"Flanagan","year":"2015","journal-title":"JAMA Neurol."},{"issue":"3","key":"10.1016\/j.msard.2022.103664_bib0030","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/bpa.12386","article-title":"Early and extensive spinal white matter involvement in neuromyelitis optica","volume":"27","author":"Hayashida","year":"2017","journal-title":"Brain Pathol."},{"key":"10.1016\/j.msard.2022.103664_bib0014","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.msard.2018.02.022","article-title":"Short transverse myelitis in Chinese patients with neuromyelitis optica spectrum disorders","volume":"21","author":"Hu","year":"2018","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"7","key":"10.1016\/j.msard.2022.103664_bib0002","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nrneurol.2010.72","article-title":"AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance","volume":"6","author":"Jarius","year":"2010","journal-title":"Nat. Rev. Neurol."},{"issue":"1\u20132","key":"10.1016\/j.msard.2022.103664_bib0007","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jns.2011.03.038","article-title":"Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: results from 211 lumbar punctures","volume":"306","author":"Jarius","year":"2011","journal-title":"J. Neurol. Sci."},{"issue":"1","key":"10.1016\/j.msard.2022.103664_bib0019","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-018-1144-2","article-title":"MOG encephalomyelitis: international recommendations on diagnosis and antibody testing","volume":"15","author":"Jarius","year":"2018","journal-title":"J. Neuroinflamm."},{"issue":"11","key":"10.1016\/j.msard.2022.103664_bib0012","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1212\/WNL.0000000000001367","article-title":"MRI characteristics of neuromyelitis optica spectrum disorder: an international update","volume":"84","author":"Kim","year":"2015","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.msard.2022.103664_bib0027","doi-asserted-by":"crossref","first-page":"209","DOI":"10.7224\/1537-2073-14.4.209","article-title":"Differentiation of neuromyelitis optica from multiple sclerosis on spinal magnetic resonance imaging","volume":"14","author":"Lalan","year":"2012","journal-title":"Int. JMS Care"},{"issue":"9451","key":"10.1016\/j.msard.2022.103664_bib0003","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis","volume":"364","author":"Lennon","year":"2004","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.msard.2022.103664_bib0009","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3390\/biomedicines8050130","article-title":"Spinal cord involvement in ms and other demyelinating diseases","volume":"8","author":"Marrodan","year":"2020","journal-title":"Biomedicines"},{"issue":"5","key":"10.1016\/j.msard.2022.103664_bib0031","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1093\/brain\/awm027","article-title":"Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese","volume":"130","author":"Matsuoka","year":"2007","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.msard.2022.103664_bib0029","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00415-008-0545-z","article-title":"Preferential spinal central gray matter involvement in neuromyelitis optica","volume":"255","author":"Nakamura","year":"2008","journal-title":"J. Neurol."},{"issue":"1","key":"10.1016\/j.msard.2022.103664_bib0025","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/ene.14038","article-title":"Spinal cord involvement by atrophy and associations with disability are different between multiple sclerosis and neuromyelitis optica spectrum disorder","volume":"27","author":"Nakamura","year":"2020","journal-title":"Eur. J. Neurol."},{"issue":"6","key":"10.1016\/j.msard.2022.103664_bib0001","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.msard.2015.08.006","article-title":"Neuromyelitis optica spectrum disorder and multiple sclerosis: differentiation by a multimodal approach","volume":"4","author":"Ota","year":"2015","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"3","key":"10.1016\/j.msard.2022.103664_bib0020","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1177\/1352458515591069","article-title":"Differentiating neuromyelitis optica from other causes of longitudinally extensive transverse myelitis on spinal magnetic resonance imaging","volume":"22","author":"Pekcevik","year":"2016","journal-title":"Mult. Scler. J."},{"issue":"9","key":"10.1016\/j.msard.2022.103664_bib0008","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1177\/1352458514531087","article-title":"Magnetic resonance imaging in neuromyelitis optica","volume":"20","author":"Tackley","year":"2014","journal-title":"Mult. Scler. J."},{"issue":"2","key":"10.1016\/j.msard.2022.103664_bib0018","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.msard.2022.103664_bib0004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00415-013-7169-7","article-title":"Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the neuromyelitis optica study group (NEMOS)","volume":"261","author":"Trebst","year":"2014","journal-title":"J. Neurol."},{"issue":"5","key":"10.1016\/j.msard.2022.103664_bib0005","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1468-1331.2009.02897.x","article-title":"Different responses to interferon beta-1b treatment in patients with neuromyelitis optica and multiple sclerosis","volume":"17","author":"Uzawa","year":"2010","journal-title":"Eur. J. Neurol."},{"issue":"2","key":"10.1016\/j.msard.2022.103664_bib0011","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.msard.2022.103664_bib0010","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1007\/s00415-018-9122-2","article-title":"Neurological update: MOG antibody disease","volume":"266","author":"Wynford-Thomas","year":"2019","journal-title":"J. Neurol."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034822001791?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034822001791?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:57:15Z","timestamp":1761901035000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034822001791"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":32,"alternative-id":["S2211034822001791"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2022.103664","relation":{},"ISSN":["2211-0348"],"issn-type":[{"type":"print","value":"2211-0348"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Centrally-located transverse myelitis would facilitate the differentiation of NMOSD and MOG-AD from MS","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2022.103664","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103664"}}